From Fundamental Molecular Biosciences to Biotherapies

Biotherapy refers to the use of molecules from living organisms to treat diseases by performing procedures such as cell and tissue therapy, gene therapy and therapies using human molecules synthesized by eukaryotic cells or bacteria, like antibodies and bioactive proteins. The field of biotherapy has advanced considerably in recent years thanks to research progress in vectorology, stem cells, biomaterials, omics and computational biology. Future researchers in biotherapy require a strong education in the molecular basis of physio-pathological processes in order to develop new biotherapy strategies. The goal of the international master’s program ‘From Fundamental Molecular Biosciences to Biotherapies’ is to provide outstanding training in fundamental molecular biosciences as applied to biotherapies through a multidisciplinary approach and in collaboration with renowned partner universities.The program, taught in English, consists of four semesters (120 ECTS) and offers students the opportunity, in addition to a high-quality education in Molecular Biosciences delivered at Sorbonne Université (Paris), to select a specialization out of various fields of biotherapies in different partner universities:- Cancer biology: Heidelberg University (Germany)- Immunology and biotherapies: Charles University (Prague, Czech Republic), Sao Paulo- University (Brasil)- Stem Cell, development and evolution: University of Lisbon (Portugal), Heidelberg University (Germany)- Bioinformatics for health sciences: Heidelberg University (Germany) and Pompeu Fabra University (Barcelona, Spain).- Fundamental molecular biosciences in biotherapies: Sorbonne Université (Paris, France)Graduates of this master’s program will emerge with an important understanding of basic and applied scientific knowledge and excellent professional and personal skills. The specializations available will allow students to obtain multiple high-level qualifications in complementary disciplines and generate career opportunities in academic research, the pharmaceutical industry and biomed, for example.